Jalessa Jones Washington, PHARMD | |
5999 Summit Bridge Rd, Townsend, DE 19734-9613 | |
(302) 696-1002 | |
Not Available |
Full Name | Jalessa Jones Washington |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 5999 Summit Bridge Rd, Townsend, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427622752 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 67667 (Texas) | Secondary |
183500000X | Pharmacist | A1-0015654 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jalessa Jones Washington, PHARMD 114 Wye Oak Dr, Townsend, DE 19734-9422 Ph: (404) 644-2844 | Jalessa Jones Washington, PHARMD 5999 Summit Bridge Rd, Townsend, DE 19734-9613 Ph: (302) 696-1002 |
News Archive
Zimbabwe could meet its target of providing 140,000 HIV-positive people with access to no-cost antiretroviral drugs by the end of the year, Owen Mugurungi, head of the Zimbabwean government's HIV/AIDS unit, said on Tuesday at a two-day workshop on drug access issues in the country, the Herald/AllAfrica.com reports (Herald/AllAfrica.com, 10/26).
Twenty years after the Rwandan Genocide left nearly 1 million dead and 2 million homeless, Binghamton University is playing a role in improving the nation's healthcare. Karen Feltham, a clinical instructor in the Decker School of Nursing, spent the 2013 fall semester in Rwanda working with women in the Rwandan Midwives Association.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have identified a previously unrecognized step in stem cell-mediated muscle regeneration.
Many rivers and streams in the United States are believed to contain a toxic antimicrobial chemical whose environmental fate was never thoroughly scrutinized despite large scale production and usage for almost half a century, according to an analysis conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.
Bayer today announced positive data on its investigational compound copanlisib, an intravenous pan-Class I phosphatidylinositol-3-kinase (PI3K) inhibitor with predominant inhibitory activity against PI3K-α and PI3K-δ isoforms.
› Verified 3 days ago
Rian Maurer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5999 Summit Bridge Rd, Townsend, DE 19734 Phone: 302-696-1002 | |
John Kenneth Mercer Price, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5999 Summit Bridge Rd, Townsend, DE 19734 Phone: 302-696-1002 | |
Franklin Russel Crowe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5999 Summit Bridge Rd, Townsend, DE 19734 Phone: 302-696-1002 | |
Paul Ojewoye, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 Karins Blvd, Townsend, DE 19734 Phone: 302-376-3668 | |
Dr. Mekbib Belete, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5999 Summit Bridge Rd, Townsend, DE 19734 Phone: 302-696-1002 | |
Godfried Arthur, PHAM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1144 E Founds St, Townsend, DE 19734 Phone: 302-449-0755 |